Delivery Order SPE2DR25D1205-SPE2DR26F1EA0

<p>The Defense Logistics Agency issued a $6,130.01 delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product.</p> <p>The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of March 13, 2026.</p>

<p>The Defense Logistics Agency issued a $1,402 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Barhemsys 10 mg/4 ml vial (4 ml), with an ultimate completion date of February 25, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.</p>

The Defense Logistics Agency issued a $4,372.81 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product. Place of performance is Conshohocken, PA. Ultimate completion date is March 5, 2026. The order is priced on a firm fixed-price basis and carries no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc., which holds a $999,999,999 indefinite delivery contract with DLA Troop...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for barhemsys 10 mg/4 ml vial with a ceiling value of $1,232.66 and an ultimate completion date of March 12, 2026.</p> <p>Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was issued under no set-aside.</p>

The Defense Logistics Agency issued a $5,735.28 delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Barhemsys 10 mg/4 ml vial pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide....

<p>The Defense Logistics Agency issued a $1,205.49 delivery order to Amerisourcebergen Drug Corp on March 19, 2026, for BARHEMSYS 10 MG/4 ML vials.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 20, 2026.</p>

The Defense Logistics Agency issued a $1,765.38 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for pharmaceutical supply (Barhemsys 5 mg/2 ml vial, 2 ml quantity). The order is issued under the DLA Troop Support Medical IDC, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 ml vials valued at $1,011.46 under a firm fixed-price contract type. The delivery order was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded. This delivery order...

The Defense Logistics Agency awarded a $34,662.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,562 vials of Barhemsys (10 mg/4 ml). The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work occurring from September 12-13, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...

The Defense Logistics Agency (DLA) awarded a $21,443.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Barhemsys 10 mg/4 mL vials. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...